share_log

Cantor Fitzgerald Reiterates Overweight on Axogen, Maintains $16 Price Target

Benzinga ·  Sep 26, 2023 11:42

Cantor Fitzgerald analyst Ross Osborn reiterates Axogen (NASDAQ:AXGN) with a Overweight and maintains $16 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment